CSI Market
Sign In | Register

Biodelivery Sciences International Inc (BDSI) Annual Income Statement

Annual · GAAP · USD millions
Access BDSI quarterly income statements →
The data below summarizes Biodelivery Sciences International Inc's income statement results from Dec 31 2017 to Dec 31 2021, enabling period-by-period comparison of operating performance.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2021)
2021 		(Dec 31 2020) (Dec 31 2019) (Dec 31 2018) (Dec 31 2017)
Revenues
Contracts Revenue0.00
Revenue From Contract With Customer Excluding Assessed Tax166.70
Total Revenue166.70
Costs & Expenses
Cost of Goods and Services Sold23.37
Gross Profit143.33
Selling, Administration, Marketing106.21
Research and Development Expense0.00
Other Operating Expense / -Income0.00
Total operating costs including COS129.58
Operating income / -loss37.12
Interest Expense7.50
Net Interest (-)Expense / Income-7.50
Business Combination, Bargain Purchase, Gain Recognized, Amount0.00
Other loss / -income0.01
Total costs & expenses137.08
Income & Taxes
Income / -loss before income taxes29.62
Income taxes expenses / -benefit-55.24
Income after income taxes84.86
Net income / -loss of other equity0.00
Income / -loss from continuing operations84.86
Preferred dividends0.00
Net income / -loss84.86
Income / -loss to shareholder84.86
EBIT37.12
EBITD37.26
EBITDA44.54
Earnings Per Share
Basic EPS (excl. extra items)0.85
Basic Net EPS0.85
Basic shares outstanding (Mill. of Units)99.32
Diluted Net EPS0.82
Diluted average shares (Mill. of Units)103.29
4 historic quarters locked

Sign in to unlock the full Biodelivery Sciences International Inc income statement history.

Sign In Create Free Account

About BDSI Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.